Usana Health Sciences shares are trading higher after the company reported better-than-expected Q2 financial results and issued FY25 guidance with its midpoints above estimates.
Usana Health Sciences shares are trading higher after the company reported better-than-expected Q2 financial results and issued FY25 guidance with its midpoints above estimates.